Journal article
Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils
CO Zlatic, Y Mao, TM Ryan, YF Mok, BR Roberts, GJ Howlett, MDW Griffin
Biochemistry | AMER CHEMICAL SOC | Published : 2015
Abstract
Protein misfolding and aggregation, leading to amyloid fibril formation, are characteristic of many devastating and debilitating amyloid diseases. Accordingly, there is significant interest in the mechanisms underlying amyloid fibril formation and identification of possible intervention tools. Small molecule drug compounds approved for human use or for use in phase I-III clinical trials were investigated for their effects on amyloid formation by human apolipoprotein (apo) C-II. Several of these compounds modulated the rate of amyloid formation by apoC-II. Epigallocatechin gallate (EGCG), a green tea catechin, was an effective inhibitor of apoC-II fibril formation, and the antipsychotic drug,..
View full abstractRelated Projects (2)
Grants
Awarded by Australian Research Council
Funding Acknowledgements
M.D.W.G is the recipient of the C.R. Roper Fellowship and an Australian Research Council Future Fellowship (project no. FT140100544). T.M.R. is supported by the Alzheimer's Australia Dementia Research Foundation Fellowship. B.R.R. is supported by the Victorian government's operational infrastructure support program and the Cooperative Research Centre for Mental Health. This work was supported by the Australian Research Council (project no. DP110103528).